Fortress Biotech, Inc. Financial Ratios — FBIO Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-441.37	-134.14	-71.93	-26.86	-76.04	-115.57	-146.87	-309.23	-284.77	-73.53	-61.91	-125.82	-213.73	-246.89	-5.18
Return on Assets (%)	-311.1	-85.79	-52.49	-21.47	-46.58	-38.08	-32.1	-43.49	-21.75	-16.62	-17.73	-25.06	-26.26	-29.51	4.13
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	100	31.13	78.79	77.22	71.25	67.99	53.36	59.37	72.91	63.8	66.92
EBITDA Margin (%)	- -	- -	- -	- -	-5,852.26	-391.89	-513.4	-438.72	-289.84	-195.06	-250.34	-256.41	-157.61	-185.13	-103.63
Operating Margin (%)	- -	- -	- -	- -	-5,855.27	-398.73	-520.71	-446.38	-302.54	-206.74	-260.21	-268.76	-164.71	-192.87	-111
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-192.87
Pretax Margin (%)	- -	- -	- -	- -	-6,243.68	-432.58	-565.46	-486.57	-277.54	-225.55	-238.92	-281.83	-181.79	-209	-53.01
Profit Margin (%)	- -	- -	- -	- -	-5,611.59	-334.31	-387.8	-313.02	-109.09	-102.03	-94.06	-114.3	-71.75	-79.75	10.77
Net Income to Common Margin (%)	- -	- -	- -	- -	-5,611.59	-334.31	-387.8	-313.02	-109.09	-102.03	-94.06	-124.91	-81.25	-96.91	-2.97
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	13.88	- -	- -	- -	- -	- -	-0.23	-1.24	-1.57	-4.23	-3.31	-0.21	-0.29	2.52	9.88
Sustainable Growth Rate (%)	-380.1	-134.14	-71.93	-26.86	-76.04	-115.57	-147.21	-313.08	-289.23	-76.64	-63.97	-126.09	-214.34	-240.67	-4.67

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	1	15	14	14	23	28	62	80	115	89	75	127	85	76	74
ST Debt	- -	2	6	- -	- -	2	13	19	9	6	7	13	6	3	2
LT Debt	1	13	7	14	23	26	49	60	106	83	68	115	79	73	72
Total Debt/EBITDA	-0.02	-0.54	-0.38	-0.7	-0.46	-0.44	-0.71	-0.67	-1.08	-1	-0.44	-0.66	-0.64	-0.71	-1.13
Net Debt/EBITDA	0.64	0.94	2.4	1.73	1.49	0.93	0.37	-0.12	0.44	1.9	1.47	0.39	0.13	-0.01	0.3
Total Debt/EBIT	-0.02	-0.54	-0.38	-0.7	-0.46	-0.43	-0.7	-0.66	-1.04	-0.94	-0.42	-0.63	-0.61	-0.68	-1.06
Net Debt/EBIT	0.64	0.94	2.4	1.73	1.48	0.91	0.36	-0.12	0.43	1.79	1.42	0.37	0.12	-0.01	0.28
EBITDA to Interest Expense	-473.27	-40.56	-18.6	-15.42	-34.03	-17.5	-11.52	-11.41	-12.45	-9.17	-15.11	-18.64	-11.18	-9.21	-7.53
EBITDA-CapEx/Interest Expense	-525.2	-40.97	-18.7	-15.42	-42.11	-20.35	-12.04	-12.31	-13.55	-9.9	-16.55	-18.94	-11.86	-10.51	-7.53
EBIT to Interest Expense	-473.57	-40.56	-18.61	-15.43	-34.05	-17.81	-11.68	-11.61	-12.99	-9.71	-15.71	-19.54	-11.68	-9.6	-8.06
Interest Expense	- -	1	2	1	1	4	8	10	9	10	11	10	12	12	9
Common Equity/Total Assets	81.85	53.75	80.81	78.95	47.93	22.55	21.38	1.31	11.58	30.09	27.41	14.18	13.46	15.76	26.88
Long-Term Debt/Equity (%)	3.92	58.02	9.12	20.24	27.5	31.56	40.89	306.06	146.33	41.98	29.91	229.31	4,986.64	- -	116.07
Long-Term Debt/Capital (%)	3.77	34.91	7.81	16.8	21.54	23.55	26.92	60.88	56.55	28.91	22.45	64.68	91.76	97.84	52.88
Long-Term Debt/Total Assets (%)	3.21	31.19	7.37	15.98	19.54	15.34	20.03	42.86	46.88	24.81	17.04	38.98	47.24	50.42	38.9
Total Debt/Equity (%)	3.92	66.19	16.75	20.47	27.67	34.01	51.87	402.69	158.75	45.22	33.19	254.56	5,334.66	-4,620.44	119.49
Total Debt/Capital (%)	3.77	39.83	14.35	16.99	21.67	25.38	34.15	80.11	61.35	31.14	24.92	71.8	98.16	102.21	54.44
Total Debt/Total Assets (%)	3.21	35.58	13.54	16.16	19.66	16.53	25.41	56.39	50.85	26.72	18.91	43.27	50.54	52.67	40.04
Net Debt to Equity	-117.13	-116.26	-105.69	-50.7	-89.01	-72.41	-26.93	70.89	-65.09	-85.79	-112.39	-149.81	-1,075.68	-80.54	-31.97
Net Debt/Capital (%)	683.65	714.93	1,857.36	-101.58	-797.02	-262.48	-36.86	41.48	-92.91	-320.57	5,191.37	8,354.63	-320.82	7.76	-34.81
EBITDA	-35	-27	-36	-21	-51	-65	-89	-118	-106	-89	-172	-194	-133	-107	-66
EBITDA-CapEx	-39	-27	-36	-21	-62	-75	-93	-127	-116	-96	-189	-197	-141	-122	-66
Operating Income (Loss)	-35	-27	-36	-21	-51	-66	-90	-120	-111	-94	-179	-204	-139	-111	-70

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	6.63	7.83	8.88	17.11	9.28	1.62	1.83	1.49	3	4.51	3.03	1.4	0.95	0.8	1.6
Current Ratio	6.69	7.91	8.92	17.28	9.45	1.94	2.56	2	3.43	5.14	3.43	1.8	1.38	1.27	2.49
Quick Ratio	6.63	7.83	8.88	17.11	9.3	1.77	1.95	1.63	3.32	4.98	3.26	1.62	1.13	0.95	2.2
CFO/Avg Current Liab	-6.27	-5.38	-3.63	-2.14	-2.78	-1.36	-1.27	-1.56	-1.88	-1.72	-1.53	-1.57	-1.21	-1.03	-1.09
Common Equity/Total Assets	81.85	53.75	80.81	78.95	47.93	22.55	21.38	1.31	11.58	30.09	27.41	14.18	13.46	15.76	26.88
Long-Term Debt/Equity (%)	3.92	58.02	9.12	20.24	27.5	31.56	40.89	306.06	146.33	41.98	29.91	229.31	4,986.64	- -	116.07
Long-Term Debt/Capital (%)	3.77	34.91	7.81	16.8	21.54	23.55	26.92	60.88	56.55	28.91	22.45	64.68	91.76	97.84	52.88
Long-Term Debt/Total Assets (%)	3.21	31.19	7.37	15.98	19.54	15.34	20.03	42.86	46.88	24.81	17.04	38.98	47.24	50.42	38.9
Total Debt/Equity (%)	3.92	66.19	16.75	20.47	27.67	34.01	51.87	402.69	158.75	45.22	33.19	254.56	5,334.66	-4,620.44	119.49
Total Debt/Capital (%)	3.77	39.83	14.35	16.99	21.67	25.38	34.15	80.11	61.35	31.14	24.92	71.8	98.16	102.21	54.44
Total Debt/Total Assets (%)	3.21	35.58	13.54	16.16	19.66	16.53	25.41	56.39	50.85	26.72	18.91	43.27	50.54	52.67	40.04
CFO/Total Liabilities	-258.12	-122.34	-153.57	-86.87	-59.35	-52.2	-64.81	-81.52	-61.71	-61.34	-68.3	-73.44	-77.27	-54.98	-53.32
CFO/CapEx	-2.85	-83.13	-157.69	- -	-1.7	-4.36	-20.26	-10.57	-10.11	-11.68	-7.13	-58.72	-15.83	-5.35	- -
Altman's Z-Score	9.79	-0.54	1.44	1.53	-0.47	-2.66	-1.4	-5.9	-2.94	-0.82	-1.7	-4.92	-8.73	-11.55	-6.45

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	18.01	3.6	4.06	3.85	2.43	2.92	2.95	3.89	4.53	3.16
Days Sales Outstanding	- -	- -	- -	- -	- -	20.27	101.47	89.99	94.85	149.95	124.8	123.65	93.78	80.54	115.43
Inventory Turnover	- -	- -	- -	- -	- -	111.81	19.56	14.43	13.72	12.91	5.7	2.56	1.88	1.69	1.74
Days Inventory Outstanding	- -	- -	- -	- -	- -	3.26	18.66	25.3	26.6	28.27	64.08	142.45	194.23	215.35	209.81
Accounts Payable Turnover	- -	- -	- -	- -	- -	0.67	0.14	0.21	0.31	0.65	1.38	0.67	0.41	0.76	0.7
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	548.72	2,613.64	1,701.99	1,187.03	564.86	264.87	544.67	887	483.05	519.45
Cash Conversion Cycle	- -	- -	- -	- -	- -	-525.19	-2,493.51	-1,586.7	-1,065.58	-386.63	-75.99	-278.57	-598.99	-187.16	-194.21
Inventory to Cash Days	- -	- -	- -	- -	- -	17	82.81	64.7	68.25	121.68	60.71	-18.79	-100.45	-134.81	-94.38
Inventories	- -	- -	- -	- -	- -	- -	- -	1	1	1	10	14	10	14	10
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	6	5	3	3
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	4	8	5	11	7
Other Inventory	- -	- -	- -	- -	- -	- -	- -	1	1	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	121	110	104	113	132	132	203	50	190	301	254	73	45	57	115
- Cash & Cash Equivalents	23	40	100	50	98	88	95	66	137	233	306	178	81	57	79
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	27	44	68	18	46	97	117	8	-21	-24	12
+ Total Debt	1	15	14	14	23	28	62	80	115	89	75	127	85	76	74
Enterprise Value	99	84	18	58	84	113	203	64	215	253	140	30	28	51	122
Total Capital	20	37	95	85	108	111	183	99	188	286	301	177	86	74	136
Total Debt/Capital (%)	3.77	39.83	14.35	16.99	21.67	25.38	34.15	80.11	61.35	31.14	24.92	71.8	98.16	102.21	54.44
Total Debt / EV	0.01	0.17	0.74	0.25	0.28	0.25	0.31	1.24	0.54	0.35	0.54	4.2	3	1.49	0.61
EV/Sales	- -	- -	- -	- -	97.46	6.86	11.77	2.38	5.87	5.55	2.04	0.4	0.33	0.88	1.93
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	50	98	80	89	132	108	166	37	141	228	204	59	24	42	102
Diluted Enterprise Value	27	72	-6	53	84	92	202	69	165	181	91	16	7	37	109
EV per Share	79.43	51.9	6.95	18.75	26.76	34.68	59.7	16.6	43.54	40.02	20.71	4.11	1.87	1.83	3.89
TTM Sales	- -	- -	- -	- -	1	16	17	27	37	46	69	76	85	58	63
TTM EBITDA	-35	-27	-36	-21	-51	-65	-89	-118	-106	-89	-172	-194	-133	-107	-66
TTM Operating Income	-35	-27	-36	-21	-51	-66	-90	-120	-111	-94	-179	-204	-139	-111	-70
TTM Cash Flow to Firm	-11	-23	-28	-15	-19	-42	-73	-89	-86	-74	-105	-169	-116	-69	-57
TTM Free Cash Flow to Firm	-7	-22	-28	-15	-7	-32	-69	-79	-77	-67	-89	-166	-108	-54	-57

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-7.01	-4.26	-2.72	-5.43	-15.67	-3.06	-2.15	-0.42	-1.64	-2.98	-2.04	-0.33	-0.2	-0.65	-1.55
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	99	84	18	58	84	113	203	64	215	253	140	30	28	51	122
Low Price	75	60	18.75	21.75	30.15	28.2	32.85	7.35	12.9	15.6	35.4	7.2	1.24	1.36	1.33
EV/Sales	- -	- -	- -	- -	97.46	6.86	11.77	2.38	5.87	5.55	2.04	0.4	0.33	0.88	1.93
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-1.42	-4.81	-5.74	-3.59	-2.95	-2.04	-2.39	-1.44	-2.31	-4.25	-4.42	-1.07	-0.92	-0.7	-33.05
Price/Earnings High	-2	-7.84	-10.4	-5.9	-5.21	-3.38	-3.2	-2.86	-3.66	-7.4	-7.7	-2.61	-2.06	-1.14	-62.27
Price/Earnings Low	-0.91	-3.14	-1.02	-2.58	-1.96	-1.36	-1.36	-0.25	-1.18	-1.61	-2.98	-0.45	-0.15	-0.51	-19.72
Price/Book Value	6.32	4.99	1.28	1.61	2.31	3.43	3.87	26.88	7.26	3	2.33	1.75	2.02	2.49	2.3
Price/Book Value Average	7.62	6.79	3.42	1.33	2.51	3.57	3.72	87.43	4.76	2.6	3.26	3.01	5.23	2.31	1.4
Price/Book Value High	10.7	11.07	6.2	2.18	4.44	5.92	4.98	173.13	7.54	4.52	5.69	7.36	11.65	3.77	2.64
Price/Book Value Low	4.86	4.43	0.61	0.96	1.67	2.39	2.12	15.31	2.43	0.98	2.2	1.27	0.83	1.67	0.84
Price/Tangible Book Value	6.32	4.99	1.28	1.61	2.37	54.1	3.94	114.62	10.1	3.51	2.64	5.02	20.16	-6.21	5.16
Price/Tangible Book Value Average	7.62	6.79	3.42	1.33	2.57	56.36	3.79	372.88	6.62	3.04	3.69	8.63	52.27	-5.74	3.14
Price/Tangible Book Value High	10.7	11.07	6.2	2.18	4.54	93.38	5.06	738.4	10.49	5.29	6.44	21.15	116.51	-9.39	5.92
Price/Tangible Book Value Low	4.86	4.43	0.61	0.96	1.7	37.67	2.16	65.31	3.38	1.15	2.49	3.65	8.3	-4.16	1.87
Price/Sales	- -	- -	- -	- -	152.42	6.55	9.64	1.39	3.84	5.01	2.97	0.77	0.29	0.73	1.61
Price/Sales Average	- -	- -	- -	- -	165.47	6.82	9.27	4.52	2.52	4.34	4.15	1.33	0.75	0.68	0.98
Price/Sales High	- -	- -	- -	- -	292.28	11.3	12.39	8.96	3.99	7.55	7.24	3.26	1.67	1.11	1.85
Price/Sales Low	- -	- -	- -	- -	109.81	4.56	5.29	0.79	1.28	1.64	2.8	0.56	0.12	0.49	0.59
Price/Cash Flow	-4.55	-4.21	-2.7	-5.43	-6.46	-2.36	-2.04	-0.38	-1.48	-2.73	-1.75	-0.33	-0.19	-0.53	-1.55
Price/Cash Flow Average	-5.48	-5.72	-7.19	-4.49	-7.01	-2.45	-1.97	-1.23	-0.97	-2.36	-2.45	-0.56	-0.49	-0.49	-0.95
Price/Cash Flow High	-7.7	-9.34	-13.04	-7.36	-12.38	-4.07	-2.63	-2.44	-1.54	-4.11	-4.28	-1.38	-1.1	-0.8	-1.78
Price/Cash Flow Low	-3.5	-3.73	-1.28	-3.22	-4.65	-1.64	-1.12	-0.22	-0.5	-0.89	-1.65	-0.24	-0.08	-0.35	-0.56
Price/Free Cash Flow Average	-8.44	-5.79	-7.24	-4.49	-17.01	-3.18	-2.07	-1.36	-1.08	-2.59	-2.85	-0.57	-0.53	-0.6	-0.95
Price/Free Cash Flow High	-11.86	-9.45	-13.12	-7.36	-30.04	-5.27	-2.76	-2.69	-1.71	-4.5	-4.97	-1.4	-1.17	-0.98	-1.78
Price/Free Cash Flow Low	-5.39	-3.78	-1.29	-3.22	-11.29	-2.13	-1.18	-0.24	-0.55	-0.98	-1.92	-0.24	-0.08	-0.43	-0.56
EV/Sales Average	- -	- -	- -	- -	110.5	7.4	13.41	7.21	4.08	4.67	3.51	1.09	1.19	0.81	1.22
EV/Sales High	- -	- -	- -	- -	237.31	12.89	17.23	13.11	6.07	8.9	7.34	3.49	2.9	1.39	2.2
EV/Sales Low	- -	- -	- -	- -	54.84	4.64	8.53	2.24	2.41	1.12	1.83	0.14	0.02	0.56	0.77
EV/EBITDA Average	-3.52	-4.56	-5.37	-2.83	-1.89	-1.89	-2.61	-1.64	-1.41	-2.4	-1.4	-0.43	-0.76	-0.44	-1.18
EV/EBITDA High	-5.2	-8.04	-11.68	-5.75	-4.06	-3.29	-3.36	-2.99	-2.09	-4.56	-2.93	-1.36	-1.84	-0.75	-2.12
EV/EBITDA Low	-2.02	-2.65	1.02	-1.56	-0.94	-1.18	-1.66	-0.51	-0.83	-0.57	-0.73	-0.05	-0.01	-0.3	-0.75
EV/EBIT Average	-3.52	-4.56	-5.36	-2.83	-1.89	-1.86	-2.57	-1.61	-1.35	-2.26	-1.35	-0.41	-0.72	-0.42	-1.1
EV/EBIT High	-5.2	-8.04	-11.67	-5.74	-4.05	-3.23	-3.31	-2.94	-2.01	-4.31	-2.82	-1.3	-1.76	-0.72	-1.98
EV/EBIT Low	-2.01	-2.65	1.02	-1.55	-0.94	-1.16	-1.64	-0.5	-0.8	-0.54	-0.7	-0.05	-0.01	-0.29	-0.7
Last Price	97.5	67.65	39.45	36.6	41.85	40.5	59.85	12.9	38.55	47.55	37.5	9.9	3.01	2.03	3.66
High Price	165	150	190.5	49.65	80.25	69.9	76.95	83.1	40.05	71.7	91.5	41.7	17.4	3.07	4.2
Enterprise Value Average	123	124	192	58	95	122	231	194	149	213	241	83	101	47	77
Enterprise Value High	182	218	418	119	205	212	297	352	222	406	505	265	245	80	139
Enterprise Value Low	71	72	-36	32	47	76	147	60	88	51	126	10	1	32	49

Shares Outstanding	1	2	3	3	3	3	3	4	5	6	7	7	15	28	31
Diluted Weighted Avg Shares	1	1	2	2	3	3	3	3	4	5	5	6	8	21	28
Basic Weighted Avg Shares	1	1	2	2	3	3	3	3	4	5	5	6	8	21	28
Revenue per Share	- -	- -	- -	- -	0.27	6.19	6.21	9.28	10.04	9.5	12.63	12.78	10.42	2.77	2.27
EBITDA per Share	-68.55	-18.82	-17.63	-8.52	-16.07	-24.24	-31.88	-40.7	-29.11	-18.53	-31.62	-32.78	-16.42	-5.14	-2.35
Operating Income per Share	-68.6	-18.82	-17.64	-8.53	-16.08	-24.66	-32.33	-41.41	-30.38	-19.64	-32.86	-34.36	-17.16	-5.35	-2.52
Basic EPS, GAAP	-82.65	-19.12	-18.32	-8.42	-15.41	-20.68	-24.08	-29.04	-10.96	-9.69	-11.88	-15.97	-8.47	-2.69	-0.07
Basic EPS from Cont Ops	-71.17	-19.12	-18.32	-8.42	-17.14	-26.76	-35.11	-45.14	-27.87	-21.45	-30.26	-36.1	-19.01	-5.81	-1.18
Diluted EPS, GAAP	-82.65	-19.12	-18.32	-8.42	-15.41	-20.68	-24.08	-29.04	-10.96	-9.69	-11.88	-15.97	-8.47	-2.69	-0.07
Diluted EPS from Cont Ops	-71.17	-19.12	-18.32	-8.42	-17.14	-26.76	-35.11	-45.14	-27.87	-21.45	-30.26	-36.1	-19.01	-5.81	-1.18
Dividend per Share	- -	- -	- -	- -	- -	- -	0.11	0.81	0.7	1.41	1.61	1.48	1.08	0.23	0.02
Cash Flow per Share	-21.44	-16.07	-14.61	-6.75	-6.48	-17.2	-29.28	-34.12	-26.03	-17.43	-21.4	-30.28	-15.81	-3.86	-2.36
Free Cash Flow per Basic Share	-28.96	-16.26	-14.71	-6.75	-10.3	-21.14	-30.72	-37.34	-28.61	-18.92	-24.4	-30.79	-16.81	-4.58	-2.36
Cash & Equivalents per Share	18.67	24.71	37.65	22.51	31.24	28.1	38.52	21.55	27.73	36.89	45.21	24.2	5.36	2.05	2.53
Book Value per Share	15.43	13.54	30.75	22.75	18.09	11.8	15.46	0.48	5.31	15.86	16.07	5.66	1.49	0.81	1.59
Tangible Book Value per Share	15.43	13.54	30.75	22.75	17.69	0.75	15.21	0.11	3.82	13.55	14.21	1.97	0.15	-0.33	0.71

Fortress Biotech, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)